VORICONAZOLE-ZP voriconazole 200mg tablet blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

voriconazole, Quantity: 200 mg

Pieejams no:

Medis Pharma Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Voriconazole

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; microcrystalline cellulose; povidone; titanium dioxide; hypromellose; triacetin; macrogol 3350

Ievadīšanas:

Oral

Vienības iepakojumā:

30, 100, 56, 10, 20, 50, 2, 14, 28

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

VORICONAZOLE-ZP is indicated for treatment of the following fungal infections:,Invasive aspergillosis.,Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,Serious fungal infections caused by Scedosporium spp and Fusarium spp.,Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation. This brand is only available as tablets and therefore only indicated for adults and children 12 years or older who can tolerate tablets.

Produktu pārskats:

Visual Identification: white, oval biconvex tablets, debossed 'VC200' on one side and plain on the reverse; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2015-02-02